GB1180233A - Modified Spiramycin - Google Patents

Modified Spiramycin

Info

Publication number
GB1180233A
GB1180233A GB8043/66A GB804366A GB1180233A GB 1180233 A GB1180233 A GB 1180233A GB 8043/66 A GB8043/66 A GB 8043/66A GB 804366 A GB804366 A GB 804366A GB 1180233 A GB1180233 A GB 1180233A
Authority
GB
United Kingdom
Prior art keywords
spiramycin
products
feb
resin
flavoured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8043/66A
Other languages
English (en)
Inventor
Jean Astruc
Andre Sambot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB8043/66A priority Critical patent/GB1180233A/en
Priority to NL6702425A priority patent/NL6702425A/xx
Priority to DE19671593741 priority patent/DE1593741A1/de
Priority to LU53049D priority patent/LU53049A1/xx
Priority to BE694496D priority patent/BE694496A/xx
Publication of GB1180233A publication Critical patent/GB1180233A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8043/66A 1966-02-23 1966-02-23 Modified Spiramycin Expired GB1180233A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB8043/66A GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin
NL6702425A NL6702425A (cs) 1966-02-23 1967-02-17
DE19671593741 DE1593741A1 (de) 1966-02-23 1967-02-17 Verfahren zur Herstellung eines Antibiotikums
LU53049D LU53049A1 (cs) 1966-02-23 1967-02-22
BE694496D BE694496A (cs) 1966-02-23 1967-02-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8043/66A GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin

Publications (1)

Publication Number Publication Date
GB1180233A true GB1180233A (en) 1970-02-04

Family

ID=9844680

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8043/66A Expired GB1180233A (en) 1966-02-23 1966-02-23 Modified Spiramycin

Country Status (5)

Country Link
BE (1) BE694496A (cs)
DE (1) DE1593741A1 (cs)
GB (1) GB1180233A (cs)
LU (1) LU53049A1 (cs)
NL (1) NL6702425A (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111719A (ja) * 1988-05-11 1990-04-24 Glaxo Group Ltd 薬物吸着質

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111719A (ja) * 1988-05-11 1990-04-24 Glaxo Group Ltd 薬物吸着質

Also Published As

Publication number Publication date
BE694496A (cs) 1967-07-31
NL6702425A (cs) 1967-08-24
DE1593741A1 (de) 1970-09-03
LU53049A1 (cs) 1967-06-16

Similar Documents

Publication Publication Date Title
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
GB1436487A (en) Compositions for oral hygiene
GB1180233A (en) Modified Spiramycin
GB1326327A (en) Process for the preparation of bis-p-chlorophenoxy-acetyl-urea
IE33371L (en) Protozoacids; aminoguanidine derivatives
GB1212943A (en) 0,1,1,3,3-pentafluoro-2-propyl p-toluenesulphonate
GB1342286A (en) Treatment of alopecia
IE34609B1 (en) Antineoplastic therapeutic compositions
GB1247821A (en) Substituted anthraquinones
GB1440850A (en) Vaso-regulator compositions
IL45087A (en) Inhalant preparations containing 3,20-dioxo-pregn-4-enoic acid derivatives
GB1395929A (en) Thioureas
GB1356991A (en) Kanamycin a salts
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof
GB1244348A (en) Fluorene derivatives
GB1385136A (en) Process of preparing 6-azauracil
GB1174177A (en) 0,2,5-Thiadiazole Derivatives
USD199814S (en) Edwin h
GB1148758A (en) Substituted ªÐ-aminobenzamides, their preparation and use
GB1328079A (en) Thiocyanatobenzothiazoles their preparation and compositions containing them
GB1345359A (en) Natiinflammatory agents
GB1264872A (cs)
JPS5271489A (en) Synthesis of josamycin derivative
GB1178806A (en) Pharmaceutical Preparations containing Butenoic Acid Derivatives
AU114166A (en) Stable aqueous. solutions'of strength resins